(Q28210949)

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

Thresholds in cerebral ischemia - the ischemic penumbra

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Dynamic penumbra demonstrated by sequential multitracer PET after middle cerebral artery occlusion in cats

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Ischemic penumbra: evidence from functional imaging in man.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Viability thresholds and the penumbra of focal ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Critical care of acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Thresholds of focal cerebral ischemia in awake monkeys

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Thrombolytic therapy for ischemic stroke--a review. Part I--Intravenous thrombolysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Thrombolytic therapy for ischemic stroke--a review. Part II--Intra-arterial thrombolysis, vertebrobasilar stroke, phase IV trials, and stroke imaging

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Thrombolytic therapy with streptokinase in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Streptokinase for acute ischemic stroke with relationship to time of administration: Australian Streptokinase (ASK) Trial Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Thrombolytic therapy in the treatment of stroke.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

The rtPA (alteplase) 0- to 6-hour acute stroke trial, part A (A0276g) : results of a double-blind, placebo-controlled, multicenter study. Thromblytic therapy in acute ischemic stroke study investigators

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

The Desmoteplase in Acute Ischemic Stroke Trial (DIAS)

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Local intra-arterial fibrinolysis in acute hemispheric stroke: effect of occlusion type and fibrinolytic agent on recanalization success and neurological outcome.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Dynamic platelet accumulation at the site of the occluded middle cerebral artery and in downstream microvessels is associated with loss of microvascular integrity after embolic middle cerebral artery occlusion

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Antiplatelet agents in the prevention and therapy of thrombosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: pathophysiologic foundation and clinical findings

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Intravenous heparin started within the first 3 hours after onset of symptoms as a treatment for acute nonlacunar hemispheric cerebral infarctions.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

The rapid anticoagulation prevents ischemic damage study in acute stroke--final results from the writing committee

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

1 reference

7 January 2021

Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Adjuvant treatment with a glycoprotein IIb/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Local intraarterial urokinase thrombolysis of acute ischemic stroke with or without intravenous abciximab: a pilot study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Intra-arterial thrombolysis for acute ischemic stroke: preliminary experience with platelet glycoprotein IIb/IIIa inhibitors as adjunctive therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial.

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021

Diagnostic imaging for acute ischemic stroke management

1 reference

https://api.crossref.org/works/10.1038%2FNCPCARDIO0721

7 January 2021